Select the Industry/ Sector 👉    All Sectors

Top Healthcare Sector Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹25,586.1
₹54,369 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,540.0
₹44,235 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,377.4
₹27,651 Cr
Pharmaceuticals & Drugs
₹812.2
₹15,964 Cr
Pharmaceuticals & Drugs
₹776.2
₹12,217 Cr
Pharmaceuticals & Drugs
₹828.9
₹7,516 Cr
Pharmaceuticals & Drugs
₹428.4
₹3,910 Cr
Pharmaceuticals & Drugs
₹294.1
₹3,293 Cr
Medical Equipment/Supplies/Accessories
₹1,424.0
₹1,222 Cr
Pharmaceuticals & Drugs
₹846.2
₹483 Cr

Top Healthcare Sector Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹812.2
₹7,784 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,540.0
₹5,776 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹776.2
₹4,502 Cr
Pharmaceuticals & Drugs
₹428.4
₹2,678 Cr
Pharmaceuticals & Drugs
₹828.9
₹1,969 Cr
Pharmaceuticals & Drugs
₹3,377.4
₹1,462 Cr
Pharmaceuticals & Drugs
₹294.1
₹750 Cr
Medical Equipment/Supplies/Accessories
₹1,424.0
₹153 Cr
Pharmaceuticals & Drugs
₹25,586.1
₹7,004 Cr
Pharmaceuticals & Drugs
₹846.2
₹364 Cr

Top Healthcare Sector Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,540.0
₹1,135 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹812.2
₹688 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹3,377.4
₹387 Cr
Pharmaceuticals & Drugs
₹776.2
₹293 Cr
Pharmaceuticals & Drugs
₹828.9
₹196 Cr
Pharmaceuticals & Drugs
₹428.4
₹191 Cr
Pharmaceuticals & Drugs
₹294.1
₹172 Cr
Medical Equipment/Supplies/Accessories
₹1,424.0
₹56 Cr
Pharmaceuticals & Drugs
₹25,586.1
₹1,615 Cr
Pharmaceuticals & Drugs
₹846.2
₹23 Cr

You may also like the below Video Courses